Early treatment for type 2 diabetes using a new duodenal procedure
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new procedure called pulsENDO, which is done in the first part of the small intestine (the duodenum) to help treat type 2 diabetes. It may be an option for people who were recently diagnosed and have good blood sugar control with little or no diabetes medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for 2 years or less
- Your HbA1c (a measure of average blood sugar over 2-3 months) is 7.5% or lower
- You take 0 or 1 oral diabetes medications (no insulin or injectables)
- You have not had any previous procedure like pulsENDO in the duodenum
- You do not have any serious stomach or bowel condition like Crohn's disease, ulcers, or bleeding
- You are not pregnant or breastfeeding and have no active cancer or bleeding disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
This trial tests a new endoscopic procedure (pulsENDO) for people with type 2 diabetes and fatty liver disease whose blood sugar remains high despite taking diabetes pills. It aims to see if this treatment can improve blood sugar control and liver health.
This trial tests a procedure that reshapes the stomach and treats the upper intestine to help control blood sugar and weight in people with obesity and type 2 diabetes. It may be an option if you have a moderate to high need for metabolic surgery.
This study tests a procedure called pulsENDO that uses pulses of energy in the upper intestine to improve blood sugar control in people with type 2 diabetes. It might help you manage your diabetes better.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This trial tests a new treatment for type 2 diabetes where stem cells are injected into the duodenum (the first part of the small intestine) using an endoscope (a thin tube). The goal is to see if this procedure is safe and possible, and it might help improve your blood sugar control.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.